Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 61 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)CompletedNCT00641238
• Tarceva Italian Lung Optimization tRialStatus unknownNCT00637910Phase 3
• N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing ChemotherapyTerminatedNCT00637624Not applicable
• Feasibility of Exercise With Post-Op Lung Cancer PatientsCompletedNCT00636571Not applicable
• Phase I Study of Vorinostat and Sorafenib in Advanced CancerCompletedNCT00635791Phase 1
• Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00633724Phase 1
• Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerTerminatedNCT00633568Phase 3
• Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLCCompletedNCT00633529Phase 1
• Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00630110Phase 1/2
• Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell CarcinomaStatus unknownNCT00625352Phase 2
• Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerCompletedNCT00622349Phase 3
• Dose Range Study of Anamorelin in Patients With Non-small Cell Lung CancerCompletedNCT00622193Phase 2
• Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLCCompletedNCT00620971Phase 2
• A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid TumorsCompletedNCT00619424Phase 1
• Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung CancerTerminatedNCT00619021Phase 1
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00616785Phase 2
• Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung CancerStatus unknownNCT00616499Phase 2
• Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00616031Phase 2
• Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IVCompletedNCT00615758Phase 2
• Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IVCompletedNCT00614965Phase 2
• Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00614809Phase 2
• Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer ScreeningTerminatedNCT00607425
• Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung CancerCompletedNCT00603057
• Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving ErlotinibCompletedNCT00602433
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00601094Phase 1
• Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00600587Phase 2
• Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentTerminatedNCT00585845Phase 1
• A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung CancerCompletedNCT00583830Phase 2
• Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung CancerCompletedNCT00582634Phase 2
• NM404 as an Imaging Agent in Patients With NSCLCCompletedNCT00582283Phase 1
• Erlotinib and Sunitinib in NSCLCCompletedNCT00581789Phase 1
• Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung CancerCompletedNCT00579683
• Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
• Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung CancerStatus unknownNCT00576914Phase 3
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLWithdrawnNCT00576225Phase 3
• Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00575393Phase 1
• Radiotherapy for NSCLC to a Individualized MLDCompletedNCT00573040
• Concurrent Chemo-radiation Form NSCLC to a Individualized MLDCompletedNCT00572325
• Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung CancerTerminatedNCT00569296Phase 1
• Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) PatientsCompletedNCT00569114Phase 1
• Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung CarcinomaTerminatedNCT00568906
• Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00568841Phase 2
• Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.TerminatedNCT00565227Phase 1
• Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLCStatus unknownNCT00561054Phase 2
• Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWithdrawnNCT00560495Phase 1
• A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00558922Phase 1/2
• A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00555256Phase 1
• Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTerminatedNCT00551733Phase 3
• Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00547443Phase 1/2
• A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung CancerCompletedNCT00544960Phase 2
• Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung CancerTerminatedNCT00543335Phase 1
• Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung CancerSuspendedNCT00540280Phase 3
• Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer PatientsTerminatedNCT00539331Phase 1
• Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung CancerCompletedNCT00536861Phase 1
• Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus BevacizumabCompletedNCT00536640Phase 2
• Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural MesotheliomaCompletedNCT00535951Phase 1
• NSCLC Relapse Therapy After Surgery and Peri-operative ChemotherapyTerminatedNCT00535275Phase 3
• Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung CancerTerminatedNCT00535015Phase 2
• A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00534027Phase 1/2
• BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
• Sorafenib in Resected Non-small Cell Lung CarcinomaTerminatedNCT00532025Phase 2
• Study of Salirasib to Treat Non-Small Cell Lung CancerCompletedNCT00531401Phase 2
• Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00530205
• A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding PhaseCompletedNCT00528281Phase 1
• CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC PatientsTerminatedNCT00526643Phase 3
• Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT00522938Phase 1/2
• Phase I Cetuximab and Concurrent Radio-chemotherapyCompletedNCT00522886Phase 1
• Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or ErlotinibCompletedNCT00522145Phase 2
• Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00517790Phase 2
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IVTerminatedNCT00516685Phase 2/3
• Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLCStatus unknownNCT00516100Phase 1/2
• Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.CompletedNCT00516022Phase 2
• Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00514293Phase 2
• Phase 1 Study of OSI-930 in Cancer PatientsCompletedNCT00513851Phase 1
• Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNCT00511576Phase 1
• Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00510445Phase 1
• GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT00509457Not applicable
• A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- BevacizumabCompletedNCT00508625Phase 2
• Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line ChemotherapyCompletedNCT00503568Phase 1
• Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic SurgeryCompletedNCT00501319
• Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
• Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung CancerActive, not recruitingNCT00499330
• Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00497315Phase 2
• Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based ChemotherapyStatus unknownNCT00497250Phase 1
• Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCompletedNCT00496275Phase 1
• Safety Study of XL999 in Adults With Non-Small-Cell Lung CancerTerminatedNCT00491699Phase 1
• Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung CancerCompletedNCT00489996Phase 2
• A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)CompletedNCT00480831Phase 2
• Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT00476216Phase 1
• Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)CompletedNCT00475098Phase 3
• Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus SorafenibTerminatedNCT00473486Phase 1/2
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerWithdrawnNCT00471835Phase 1/2
• Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
• Phase II Trial of Tarceva in Patients With Non-Small Cell Lung CancerStatus unknownNCT00466284Phase 2
• Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung CancerStatus unknownNCT00466089Phase 2
• Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung CancerCompletedNCT00464282
• Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLCCompletedNCT00463515Phase 2
• Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)CompletedNCT00462995Phase 2
• A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)TerminatedNCT00461110Phase 1
• MONET1-MOtesanib NSCLC Efficacy and Tolerability StudyTerminatedNCT00460317Phase 3

← Carcinoma, Non-Small-Cell Lung overview